Enlivex Therapeutics Ltd.(ENLV)

Biotechnology · Ness Ziona, TA

$0.34-0.02 (-6.02%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

Operating Cash Flow Yield: N/A

Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The operating cash flow yield is N/A as of 2026-10-06T21:26:28.653Z.

Stored calculation inputs

Calculation as of: 2026-10-06T21:26:28.653Z.

Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

TTM operating cash flow · period ending 2026-06-30: -15,804,857
Quote market capitalization: 5,726,252

FMP input reference: 16b0ce149acf027305ec47ed69e441f7c4eae43bc3095c7aeda967d53938ba16

P/OCF Ratio|FCF Yield|Earnings Yield|EBITDA Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

ENLV Operating Cash Flow Yield Metrics

OPERATING CASH FLOW YIELD

N/A

ENLV Competitors' Operating Cash Flow Yield

ENLV

Enlivex Therapeutics Ltd.

Current

Market Cap

$5.73M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NVNO

enVVeno Medical Corporation

vs ENLV

Market Cap

$5.70M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CUPR

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

vs ENLV

Market Cap

$5.82M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ACXP

Acurx Pharmaceuticals, Inc.

vs ENLV

Market Cap

$5.63M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LUCY

Lucyd, Inc

vs ENLV

Market Cap

$5.83M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SNOA

Sonoma Pharmaceuticals, Inc.

vs ENLV

Market Cap

$5.89M

Operating Cash Flow Yield

N/A

TTM Avg

6.96%

3Y Avg

6.96%

5Y Avg

6.96%

CDIO

Cardio Diagnostics Holdings, Inc.

vs ENLV

Market Cap

$5.92M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LEXX

Lexaria Bioscience Corp.

vs ENLV

Market Cap

$5.35M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SCNX

Scienture Holdings, Inc.

vs ENLV

Market Cap

$6.11M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GELS

Gelteq Limited Ordinary Shares

vs ENLV

Market Cap

$5.32M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	OPERATING CASH FLOW YIELD	TTM	3Y	5Y
Enlivex Therapeutics Ltd. (ENLV)	$5.73M	N/A	N/A	N/A	N/A
enVVeno Medical Corporation (NVNO)vs ›	$5.70M	N/A	N/A	N/A	N/A
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs ›	$5.82M	N/A	N/A	N/A	N/A
Acurx Pharmaceuticals, Inc. (ACXP)vs ›	$5.63M	N/A	N/A	N/A	N/A
Lucyd, Inc (LUCY)vs ›	$5.83M	N/A	N/A	N/A	N/A
Sonoma Pharmaceuticals, Inc. (SNOA)vs ›	$5.89M	N/A	6.96%	6.96%	6.96%
Cardio Diagnostics Holdings, Inc. (CDIO)vs ›	$5.92M	N/A	N/A	N/A	N/A
Lexaria Bioscience Corp. (LEXX)vs ›	$5.35M	N/A	N/A	N/A	N/A
Scienture Holdings, Inc. (SCNX)vs ›	$6.11M	N/A	N/A	N/A	N/A
Gelteq Limited Ordinary Shares (GELS)vs ›	$5.32M	N/A	N/A	N/A	N/A

Operating Cash Flow Yield Formula & Definition

OCF Yield = TTM Operating Cash Flow / Market Cap

Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Operating Cash Flow Yield: N/A

ENLV Operating Cash Flow Yield Metrics

ENLV Competitors' Operating Cash Flow Yield

Operating Cash Flow Yield Formula & Definition

Related Metrics